Cytomegalovirus Infection
📧 Sign up to get email alerts when something new happens for Cytomegalovirus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: The Natural History of Severe Viral Infections and Characterization of Immune Defects in Patients Without Known Immunocompromise
This clinical trial studies the natural history of severe viral infections and characterizes immune defects in patients without known immuno…
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077) [Phase 1]
Phase 1 clinical study evaluating letermovir (MK-8228) for cytomegalovirus prophylaxis in children and adolescents receiving a kidney transp…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients [Phase 1]
This Phase 1 clinical trial at MD Anderson is evaluating the feasibility, safety, and efficacy of genetically engineered glucocorticoid rece…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Individualised Dose Optimisation of Ganciclovir in Immunocompromised Children Trial (ID-MAGIC) [Phase 2]
A Phase 2 clinical trial (ID-MAGIC) is evaluating individualized dosing of ganciclovir in immunocompromised children with Cytomegalovirus in…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection [Phase 2]
A Phase 2 clinical trial update for anti-CMV therapy in breast cancer patients with progressive intracranial metastases and CMV infection, c…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II [Phase 2]
Phase 2 clinical trials evaluating systemic and topical antiviral therapies for Cytomegalovirus anterior uveitis are described, with the tri…
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: Burden of Cytomegalovirus Reactivation in Pediatric Patients After Allogeneic Hematopoietic Stem Cell Transplantation
A pediatric clinical trial is examining the burden of cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation …
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant Candidates [Phase 2]
An ongoing Phase 2 clinical trial is evaluating a cytomegalovirus vaccine in orthotopic liver transplant candidates and is currently recruit…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients [Phase 3]
Phase 3 trial update describing the initiation of de-novo prophylaxis with Letermovir vs Valganciclovir for cytomegalovirus in adult kidney …
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients [Phase 3]
Phase 3 clinical trial evaluating preemptive therapy or prophylaxis to prevent CMV infection in donor CMV-positive/recipient CMV-negative ki…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission [EARLY_Phase 1]
An early-phase clinical trial is investigating ex vivo renal perfusion with SYN002 to prevent Cytomegalovirus transmission in kidney transpl…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Breakthrough CMV Lung Transplant -Multicentre
An ongoing multicentre clinical trial sponsored by the University of Alberta is recruiting to evaluate a breakthrough approach for cytomegal…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections [Phase 3]
A Phase 3 clinical trial evaluating maribavir for cytomegalovirus infection in Chinese adults is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration
This clinical trial update describes a study to test an immune-reconstitution-based scoring system to guide the duration of letermovir proph…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial comparing valganciclovir prophylaxis versus preemptive therapy for cytomegalovirus infection in living donor kidney t…
-
CLINICAL_TRIALS research · 2026-02-23Clinical Trial Update: Haplo-identical Viral-Specific T-cells for Treatment of Cytomegalovirus and Adenovirus Infections After Hematopoietic Cell Transplantation [Phase 2]
Phase 2 clinical trial evaluating haplo-identical viral-specific T cells to treat cytomegalovirus and adenovirus infections after hematopoie…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Effectiveness of an Immune-guided Cytomegalovirus Infection Preventive Strategy Compared to a Universal Prophylactic Strategy in Renal Transplant Patients [Phase 3]
Phase 3 trial comparing an immune-guided cytomegalovirus prevention strategy to universal prophylaxis in kidney transplant recipients; curre…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection [Phase 2]
Phase 2 clinical trial evaluating donor CMV-specific cytotoxic T lymphocytes for persistent cytomegalovirus infection in patients with hemat…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Combination Letermovir and Standard of Care Antiviral for Enhanced Antiviral Response in Cytomegalovirus Infection in Lung Transplant Recipients [Phase 4]
A Phase 4 clinical trial is evaluating the combination of letermovir with standard-of-care antivirals for cytomegalovirus infection in lung …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant
This clinical trial update describes ongoing strategies for CMV infection prophylaxis and management in patients with hematologic malignanci…
-
CLINICAL_TRIALS research · 2026-01-27Clinical Trial Update: Casting Light on HOst-cytomegaloviRUs Interaction in Solid Organ Transplantation
Active-not-recruiting clinical trial updating on host Cytomegalovirus interactions in solid organ transplantation, sponsored by University H…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Single Arm Pilot Trial of Letermovir for CMV Prophy in CAR T Cell [Phase 2]
This update describes a Phase 2 single-arm pilot trial of letermovir for cytomegalovirus prophylaxis in patients receiving CAR T-cell therap…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Efficacy of Extended Letermovir Prophylaxis to Prevent CMV Reactivation in High-Risk Chinese Adults Undergoing Allogeneic HSCT [NA]
The document reports a clinical trial evaluating extended letermovir prophylaxis to prevent CMV reactivation in high-risk Chinese adults und…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: Letermovir-based Dual Therapy for Treatment of Cytomegalovirus Infections [Phase 3]
A Phase 3 clinical trial is evaluating a letermovir-based dual therapy for treating cytomegalovirus infections and is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-22Clinical Trial Update: Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) [Phase 4]
A Phase 4 clinical trial is evaluating intravenous immunoglobulin to prevent late cytomegalovirus disease in organ transplant recipients and…